Barbara J. Weiblen
- Virology top 2%
- HIV Research and Treatment 4
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions 4
- Hematology top 10%
- Blood groups and transfusion 6
- Hematopoietic Stem Cell Transplantation 3
- Emergency Medicine top 10%
-
- Radiopharmaceutical Chemistry and Applications 3
-
- Blood disorders and treatments 3
-
- Neutropenia and Cancer Infections 3
-
- Erythrocyte Function and Pathophysiology 2
- Co-authors
- Rodney HoffGeorge F. GradyVictor P. BerardiMarvin L. MitchellJeffrey McCulloughL FörströmRichard SchumacherPeter Olson
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Barbara J. Weiblen
20 papers receiving 650 citations
Peers
Comparison fields: 5 of 87
- Virology 244
- Infectious Diseases 316
- Hematology 136
- Emergency Medicine 72
- Immunology 127
Countries citing papers authored by Barbara J. Weiblen
This map shows the geographic impact of Barbara J. Weiblen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara J. Weiblen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara J. Weiblen more than expected).
Fields of papers citing papers by Barbara J. Weiblen
This network shows the impact of papers produced by Barbara J. Weiblen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara J. Weiblen. The network helps show where Barbara J. Weiblen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Barbara J. Weiblen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 16 | |
| 2 | 1992 | 27 | |
| 3 | Newborn screening for congenital Toxoplasma infection: five years experience in Massachusetts, USA. | 1992 | 14 |
| 4 | 1991 | 3 | |
| 5 | Clinical utility of HIV-IgA immunoblot assay in the early diagnosis of perinatal HIV infection. | 1991 | 41 |
| 6 | 1990 | 46 | |
| 7 | 1990 | 88 | |
| 8 | 1988 | 212 | |
| 9 | 1984 | 19 | |
| 10 | 1984 | 21 | |
| 11 | 1983 | 34 | |
| 12 | 1983 | 4 | |
| 13 | 1982 | 8 | |
| 14 | 1980 | 4 | |
| 15 | Studies of the kinetics of indium-111-labeled granulocytes. | 1979 | 63 |
| 16 | 1979 | 17 | |
| 17 | 1976 | 70 | |
| 18 | 1976 | 9 | |
| 19 | 1974 | 9 | |
| 20 | Citrate phosphate dextrose (CPD) anticoagulant in blood transfusion. | 1973 | 3 |
About Barbara J. Weiblen
Barbara J. Weiblen is a scholar working on Hematology, Virology and Infectious Diseases, having authored 20 papers that have together received 708 indexed citations. Recurring topics across this work include Blood groups and transfusion (6 papers), HIV Research and Treatment (4 papers), HIV/AIDS Research and Interventions (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Blood disorders and treatments (3 papers), Neutropenia and Cancer Infections (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Virology (244 citations), Infectious Diseases (316 citations) and Hematology (136 citations). Barbara J. Weiblen has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Rodney Hoff, George F. Grady, Victor P. Berardi, Marvin L. Mitchell, Jeffrey McCullough, L Förström, Richard Schumacher, Peter Olson, James J. O’Leary and Sheldon H. Landesman. Their work appears in journals such as New England Journal of Medicine, The Lancet and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.